MedPath
FDA Approval

Kovanaze

November 16, 2018

HUMAN PRESCRIPTION DRUG LABEL

Tetracaine(30 mg in 1 mL)
Oxymetazoline(0.5 mg in 1 mL)

Products (1)

Kovanaze

69803-100

NDA208032

NDA (C73594)

NASAL

November 16, 2018

SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULRClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: 5NF5D4OPCIClass: ACTIBQuantity: 30 mg in 1 mL
BENZYL ALCOHOLInactive
Code: LKG8494WBHClass: IACT
HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)Inactive
Code: S38J6RZN16Class: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
Code: K89MJ0S5VYClass: ACTIBQuantity: 0.5 mg in 1 mL

Drug Labeling Information

RECENT MAJOR CHANGES SECTION

RECENT MAJOR CHANGES

Warnings and Precautions, Methemoglobinemia ( 5.1) 11/2018


© Copyright 2025. All Rights Reserved by MedPath